Lincoln Pharmaceuticals Limited (NSE:LINCOLN)

Lincoln Pharmaceuticals Revenue

Lincoln Pharmaceuticals had revenue of 1.66B INR in the quarter ending December 31, 2025, with 13.49% growth. This brings the company's revenue in the last twelve months to 6.52B, up 9.10% year-over-year. In the fiscal year ending March 31, 2025, Lincoln Pharmaceuticals had annual revenue of 6.23B with 7.35% growth.

• Revenue (ttm): 6.52B
• Revenue Growth: +9.10%
• P/S Ratio: 2.25
• Revenue / Employee: 3.52M
• Employees: 1,853
• Market Cap: 14.69B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	6.23B	426.81M	7.35%
Mar 31, 2024	5.81B	702.41M	13.76%
Mar 31, 2023	5.10B	381.86M	8.09%
Mar 31, 2022	4.72B	479.38M	11.30%
Mar 31, 2021	4.24B	376.95M	9.75%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 22, 2026

Data Sources Report a data error